SCHEMBL31702342

SCHEMBL31702342

Nc1cc(F)c(Br)cc1NC1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.39
KDM1A O60341 8/20 0.36
KDM1B Q8NB78 5/20 0.36
KCNH2 Q12809 4/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.34
GLA P06280 1/20 0.32
ADRB2 P07550 2/20 0.31
ALOX15 P16050 2/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA3 P07451 1/20 0.31
CA4 P22748 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25335478 0.93 ROCK2 (0.42) ROCK2KDM1AKDM1BKCNH2GAA
SCHEMBL8244028 0.89 HRH3 (0.36) ROCK2KDM1AKDM1BKCNH2GAA
SCHEMBL28974855 0.85 ROCK2 (0.42) ROCK2KDM1AKDM1BKCNH2GAA
SCHEMBL29525834 0.85 ROCK2 (0.46) ROCK2KDM1AGAAMAPTKDM4E
SCHEMBL10175794 0.85 ROCK2 (0.46) ROCK2KDM1AGAAMAPTKDM4E
SCHEMBL22724888 0.85 KDM1A (0.33) KDM1AKDM1BKCNH2PIM1
SCHEMBL23175499 0.79 CA1 (0.37) GAAMAPTKDM4EALOX15CA12
SCHEMBL20337719 0.79 ROCK2 (0.39) ROCK2KDM1AKDM1BKCNH2GAA
SCHEMBL31149474 0.79 ROCK2 (0.39) ROCK2KDM1AKDM1BKCNH2GAA
SCHEMBL20349186 0.78 GAA (0.46) ROCK2GAAMAPTKDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 ROCK2 4018/4885KDM1A 174/4885KDM1B 133/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 ROCK2 3972/4885KDM1A 569/4885KDM1B 673/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 ROCK2 4018/4885KDM1A 174/4885KDM1B 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.